未登录

J

Janvi Sah

h oncology market access and pricing, astrazeneca, gaithersburg, md, usa

H指数:10

被引数:365

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancers

LIVER-R研究方案：一项关于 durvalumab为基础方案在肝胆肿瘤患者中的全球真实世界研究

Future Oncology

IF2.6

2025-11-240

OAAI

Patient Experience of Hepatocellular Carcinoma and Their Treatment Goals: An International Qualitative Study and Patient Journey Map

ADVANCES IN THERAPY

IF4

2024-07-250

OAAI

Direct and Indirect Costs of Breast Cancer and Associated Implications: A Systematic Review

乳腺癌的直接和间接成本及其相关影响: 系统综述

ADVANCES IN THERAPY

IF4

2024-06-042

OAAI

Incidence and Costs of Clinically Significant Events with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study

ADVANCES IN THERAPY

IF4

2024-03-051

OAAI

Real-world treatment patterns in patients with biliary tract cancer (BTC): Retrospective chart review survey in Europe (GARNET-2)

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

OA

Patients' prioritization of treatment goals in hepatocellular carcinoma (HCC): A global qualitative observational study (PERIDOT)

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

PRE

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences

ADVANCES IN THERAPY

IF4

2023-02-224

OAAI

Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease

THROMBOSIS AND HAEMOSTASIS

IF4.3

2021-12-2824

OAAI

Effectiveness and Safety of Apixaban Versus Warfarin Among Older Patients with Venous Thromboembolism with Different Demographics and Socioeconomic Status

ADVANCES IN THERAPY

IF4

2021-09-278

OAAI

Effectiveness and Safety of Apixaban vs. Warfarin in Venous Thromboembolism Patients with Obesity and Morbid Obesity

JOURNAL OF CLINICAL MEDICINE

IF2.9

2021-01-0827

OAAI

Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A US Claims Data Analysis

THROMBOSIS AND HAEMOSTASIS

IF4.3

2020-11-1030

OAAI

Treatment patterns of metastatic castration-sensitive prostate cancer (mCSPC): A real-world evidence study

ANNALS OF ONCOLOGY

IF65.4

2020-09-0110

OAAI

Evaluating the Effect of Standard of Care Treatment on Burden of Chronic Hepatitis B: A Retrospective Analysis of the United States Veterans Population

ADVANCES IN THERAPY

IF4

2020-02-025

OAAI

HEALTH CARE UTILIZATION AND ECONOMIC BURDEN OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN THE US DEPARTMENT OF DEFENSE POPULATION

VALUE IN HEALTH

IF6

2018-05-010

OAAI

PATIENT-RELATED BARRIERS TO MEDICATION ADHERENCE IN TYPE 2 DIABETIC PATIENTS: A SYSTEMATIC REVIEW

VALUE IN HEALTH

IF6

2016-05-011

OAAI